In patients with stroke or TIA and CYP2C19 loss-of-function alleles, ticagrelor vs. clopidogrel reduced 90-d stroke

被引：1
|
作者：
Joundi, Raed A. [1 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
来源：
ANNALS OF INTERNAL MEDICINE | 2022年 / 175卷 / 03期
关键词：
MINOR STROKE; ASPIRIN;
D O I：
10.7326/J22-0008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：JC30 / JC30
页数：1
相关论文
共 50 条
  • [1] Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA
    Wang, Yongjun
    Meng, Xia
    Wang, Anxin
    Xie, Xuewei
    Pan, Yuesong
    Johnston, S. Claiborne
    Li, Hao
    Bath, Philip M.
    Dong, Qiang
    Xu, Anding
    Jing, Jing
    Lin, Jinxi
    Niu, Siying
    Wang, Yilong
    Zhao, Xingquan
    Li, Zixiao
    Jiang, Yong
    Li, Wei
    Liu, Liping
    Xu, Jie
    Chang, Liguo
    Wang, Lihua
    Zhuang, Xianbo
    Zhao, Jinguo
    Feng, Yefang
    Man, Honghao
    Li, Guozhong
    Wang, Baojun
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (27): : 2520 - 2530
  • [2] Ticagrelor Aspirin vs Clopidogrel Aspirin in CYP2C19 Loss-of-Function Carriers With Minor Stroke or TIA Stratified by Risk Profile
    Wang, Anxin
    Meng, Xia
    Tian, Xue
    Zuo, Yingting
    Bath, Philip M. M.
    Li, Hao
    Xie, Xuewei
    Jing, Jing
    Lin, Jinxi
    Wang, Yilong
    Zhao, Xingquan
    Liu, Liping
    Li, Zixiao
    Jiang, Yong
    Xu, Jie
    Wang, Feng
    Chen, Weifeng
    Cao, Minghua
    Li, Jianhua
    Wang, Yongjun
    NEUROLOGY, 2023, 100 (05) : E497 - E504
  • [3] One-Year Outcomes of Early Therapy With Ticagrelor vs Clopidogrel in CYP2C19 Loss-of-Function Carriers With Stroke or TIA Trial
    Meng, Xia
    Wang, Anxin
    Tian, Xue
    Johnston, Claiborne
    Li, Hao
    Bath, Philip M.
    Xu, Qin
    Zhang, Yijun
    Xie, Xuewei
    Jing, Jing
    Lin, Jinxi
    Wang, Yilong
    Zhao, Xingquan
    Li, Zixiao
    Jiang, Yong
    Liu, Liping
    Wang, Yongjun
    NEUROLOGY, 2024, 102 (03) : e207809
  • [4] Ticagrelor Versus Clopidogrel in Patients with Two CYP2C19 Loss-of-Function Alleles Undergoing Percutaneous Coronary Intervention
    Ziwei Xi
    Yujie Zhou
    Yingxin Zhao
    Xiaoli Liu
    Jing Liang
    Meng Chai
    Ying Yu
    Wei Liu
    Cardiovascular Drugs and Therapy, 2020, 34 : 179 - 188
  • [5] Ticagrelor Versus Clopidogrel in Patients with Two CYP2C19 Loss-of-Function Alleles Undergoing Percutaneous Coronary Intervention
    Xi, Ziwei
    Zhou, Yujie
    Zhao, Yingxin
    Liu, Xiaoli
    Liang, Jing
    Chai, Meng
    Yu, Ying
    Liu, Wei
    CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (02) : 179 - 188
  • [6] Influence of CYP2C19*2 and*3 loss-of-function alleles on phenotyping and clopidogrel pharmacodynamics
    Jeong, Y. H.
    Koh, J. S.
    Park, Y. H.
    Hwang, J. Y.
    Kwak, C. H.
    EUROPEAN HEART JOURNAL, 2013, 34 : 898 - 898
  • [7] CYP2C19 loss-of-function alleles: A common but overlooked problem associated with clopidogrel resistance
    Chi, Nai-Fang
    Wang, Shuu-Jiun
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2019, 82 (10)
  • [8] Increased frequency of CYP2C19 loss-of-function alleles in clopidogrel-treated patients with recurrent cerebral ischemia
    Minderhoud, Crista
    Otten, Leila S.
    Hilkens, Pieter H. E.
    van den Broek, Marcel P. H.
    Harmsze, Ankie M.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (07) : 3335 - 3340
  • [9] PHARMACOGENOMICS IN STROKE: CYP2C19 LOSS-OF-FUNCTION IS ASSOCIATED WITH INCREASED RISK OF ISCHEMIC STROKE FOR CAROTID ARTERY STENOSIS PATIENTS
    Patel, P.
    Niu, X.
    Shannon, C.
    Fusco, M.
    Chitale, R.
    Peterson, J.
    INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 80 - 80
  • [10] CYP2C19 loss-of-function alleles and use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel
    Ramste, Markus
    Ritvos, Markus
    Hayrynen, Sergei
    Kiiski, Johanna I.
    Niemi, Mikko
    Sinisalo, Juha
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (10): : 2010 - 2020
12345